Trending Now
BUSINESS
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...
Cellectis a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has...
MEDICAL DEVICES
MANUFACTURING
MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy...
MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform
DON'T MISS
JOURNAL SPOTLIGHT
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
LAGUNA HILLS, Calif., Dec. 27, 2016 - PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
EVEN MORE NEWS
